RxDoctor Payments Data

Nathan Sneddon, MD

Pain Medicine · Spokane Valley, WANPI 1427232925

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.4%. Reporting peaked in 2022 at $7,410 and has fallen 84.0% since, to $1,189 in 2025. Among pain medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,670in general payments, 2019–2025

Across 296 payments — averaging $66.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Relievant Medsystems, Inc.$3K
  • Nevro Corp.$3K
  • Vertos Medical, Inc.$2K
  • Stimwave Technologies Incorporated$2K
  • Boston Scientific$1K
  • plus $4K from 24 others
$220,474in ownership & investment interests, 2019–2025

Across 10 payments — averaging $22,047 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spinal Simplicity, LLC$220K

What the payments were for

  • Consulting fees$1431%
  • Travel & lodging$9,04446%
  • Food & beverage$10,48253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,670 in reported general payments places this provider in the 90th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$409,581
Medicare patients
347
Services billed
5,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl31$419
RizatriptanRizatriptan Benzoate12$348
Oxycodone Hcl15$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$124
Cephalexin18$52
Diazepam18$50

Paid to pharmacies, not to this prescriber.

Other pain medicine in Spokane Valley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →